Pathophysiological Study on Thoracic Ascending Aorta of Mice with Myh11R247C Heterozygous Mutation in Norepinephrine-induced Hypertension Model

YANG Yun, WU Zhou-peng, SHU Ye, Sweeney H Lee, HUANG Bin

Abstract

To explore the thoracic ascending aortic （TAA） pathophysiological characteristics of heterozygous mutant Myh11R247C/+ mice under the norepinephrine-induced hypertension mode.  Methods  Female heterozygous mutant Myh11R247C/+ and wild type Myh11+/+ mice were selected as experimental group (HET group) and control group (WT group), respectively. The hypertensive model was induced by intraperitoneal injection of norepinephrine (NE), and TAA diameter and invasive blood pressure (Bp) data were collected dynamically in real time using high-frequency ultrasound imaging and invasive arterial blood pressure monitoring technique, so as to indirectly analyze TAA compliance of two groups of mice. At the same time, the incidences of hemothorax and TAA rupture were further analyzed by autopsy and histology.  Results  After injection of NE, heterozygous mice did not show a higher Bp increase percentage in systole or diastole comparing with wildtype mice. However, heterozygous mice exhibited 17% and 32% higher TAA diameter dilation percentage than wildtype ones in systole and diastole respectively. Two heterozygous mice had TAA dissection and rupture, and the incidence of hemothorax in heterozygous mice (3/5) was higher than that in wildtype (0/5).  Conclusion  It was very likely that the altered TAA wall compliance of mutant Myh11R247C/+ mice had led to a higher TAA dilation degree than that in wildtype, and even could be the potential reason of TAA dissection and rupture.

 

Keywords: Thoracic ascending aorta, Myh11, Norepinephrine, Invasive blood pressure, High-frequency ultrasound

 

Full Text:

PDF


References


DANYI P， ELEFTERIADES J A， JOVIN I S. Medical therapy of thoracic aortic aneurysms. Trends Cardiovasc Med，2012，22(7): 180–184.

GLEASON T G， BENJAMIN L C. Conventional open repair of descending thoracic aortic aneurysms. Perspect Vasc Surg Endovasc Ther，2007，19(2): 110–121.

HOMME J L， AUBRY M C， EDWARDS W D， et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol，2006，30(9): 1159–1168.

BROWNSTEIN A J，ZIGANSHIN B A，ELEFTERIADES J A. Human aortic aneurysm genomic dictionary: is it possible? Indian J Thorac Cardiovasc Surg，2019，35(2): 1–10.

VINHOLO T， ZAFAR M， ZIGANSHIN B， et al. Non-syndromic thoracic aortic aneurysms and dissections – Is screening possible? Semin Thorac Cardiovasc Surg，2019，31(4): 628–634.

KARIMI A， MILEWICZ D M. Structure of the Elastin-Contractile Units in the thoracic aorta and how genes that cause thoracic aortic aneurysms and dissections disrupt this structure. Can J Cardiol，2016，32(1): 26–34.

IKEDA Y. Aortic aneurysm: etiopathogenesis and clinicopathologic correlations. Ann Vasc Dis，2016，9(2): 73–79.

ISSELBACHER E M， CARDENAS C L L， LINDSAY M E. Hereditary influence in thoracic aortic aneurysm and dissection. Circulation，2016， 133(24): 2516–2528.

MORISAKI T， MORISAKI H. Genetics of hereditary large vessel diseases. J Hum Genet，2016，61(1): 21–26.

MILEWICZ D M， REGALADO E S， SHENDURE J， et al. Successes and challenges of using whole exome sequencing to identify novel genes underlying an inherited predisposition for thoracic aortic aneurysms and acute aortic dissections. Trends Cardiovasc Med，2014，24(2): 53–60.

POMIANOWSKI P， ELEFTERIADES J A. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg，2013，2(3): 271–279.

MILEWICZ D M， GUO D C， TRAN-FADULU V， et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet，2008，9(1): 283–302.

ALBORNOZ G， COADY M A， ROBERTS M， et al. Familial thoracic aortic aneurysms and dissections—incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg，2006，82(4): 1400–1405. COADY M A， DAVIES R R， ROBERTS M， et al. Familial patterns of thoracic aortic aneurysms. Arch Surg，1999，134(4): 361–367.

BIDDINGER A， ROCKLIN M， COSELLI J S， et al. Familial thoracic aortic dilatations and dissections : a case control study. J Vasc Surg，1997， 25(3): 506–511.

KERAVNOU A， BASHIARDES E， MICHAILIDOU K， et al. Novel variants in the ACTA2 and MYH11 genes in a Cypriot family with thoracic aortic aneurysms: a case report. BMC Med Genet， 2018， 19(1): 208[2019-08-16]. https://bmcmedgenet.biomedcentral.com/articles/10.1186/s12881-018-0728-0. doi: 10.1186/s12881-018-0728-0.

BELLINI C， WANG S， MILEWICZ D M， et al. Myh11(R247C/R247C) mutations increase thoracic aorta vulnerability to intramural damage despite a general biomechanical adaptivity. J Biomech，2015，48(1): 113–121.

TAKEDA N， MORITA H， FUJITA D， et al. A deleterious MYH11 mutation causing familial thoracic aortic dissection. Hum Genome Var， 2015，2(1): 15028–15028.

PANNU H， TRANFADULU V， PAPKE C L， et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin Ⅱ. Hum Mol Genet，2007，16(20): 2453–2462.

ZHU L， VRANCKX R， VAN KIEN P K， et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet， 2006，38(3): 343–349.

ZHU L， BONNET D， BOUSSION M， et al. Investigation of the MYH11 gene in sporadic patients with an isolated persistently patent arterial duct. Cardiol Young，2007，17(6): 666–672.

KUANG S Q K， CALLIE S， BYANOVA KATERINA L， et al. Rare,nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells. Circ Res，2012，110(11): 1411–1422.

GAO S， HO D， VATNER D E， et al. Echocardiography in Mice. Curr Protoc Mouse Biol，2011，1: 71–83.

PACHER P， NAGAYAMA T， MUKHOPADHYAY P， et al. Measurement of cardiac function using pressure–volume conductance


Refbacks

  • There are currently no refbacks.